Treatment Outcomes in Adults with Acute Myeloid Leukemia (AML) Using Standard Induction “3+7”, Hypomethylating Agents or Best Supportive Care: A Single Institution Experience

Authors

Bolanle Gbadamosi, William Beaumont Hospital
Susanna Gaikazian, William Beaumont Hospital
Ishmael Jaiyesimi, William Beaumont Hospital

Document Type

Article

Publication Date

9-2017

Comments

Society of Hematologic Oncology (SOHO) Annual Meeting, Houston, TX, September 13-16, 2017.

Recommended Citation

Gbadamosi B, Bastola S, Ye H, Fennell T, Mora E, Hart B, et al, [Gaikazian S, Jaiyesimi I]. Treatment outcomes in adults with acute myeloid leukemia (AML) using standard induction"3+7", hypomethylating agent or best supportive care: A single institution experience. Clin Lymph Myelo Leuk. 2017 Sept;17(2). Society of Hematologic Oncology (SOHO) Annual Meeting, Houston, TX, September 13-16, 2017.